Over up to seven years of follow-up, those treated with semaglutide or tirzepatide had a 37% lower risk of developing dementia (hazard ratio [HR] 0.63, 95% CI 0.500.81), a 19% lower risk of stroke (HR 0.81, 95% CI 0.700.93), and a 30% lower risk of all-cause mortality (HR 0.70, 95% CI 0.630.78), compared to those on other antidiabetic drugs
Mantngase al da con Pivot Obtenga acceso gratuito a Pivot, la aplicacin de seguimiento de GLP-1 diseada para ayudarle a registrar sus dosis, hacer un seguimiento de los efectos secundarios, monitorear sus hbitos y ver su progreso claramente, todo en un solo lugar
some people report increased hunger before their next weekly dose as plasma concentrations decline
Additionally, patients need to know that the healing process is not the same for everyone
Look forward to: Better liver function with less inflammation Firmer, healthier skin even in sun-exposed areas Lasting improvements in your metabolic health When to expect results Your wellness journey unfolds in clear stages: Weeks 1-2: Foundation Phase Your cells begin their renewal journey
all of which are considered valid and reliable measures of psychiatric symptom severity (7678)